Novartis AG

NVS · NYSE
Analyze with AI
9/29/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$9,556$6,656$7,066$11,459
Short-Term Investments$197$344$130$1,892
Receivables$8,984$9,176$8,725$8,211
Inventory$6,421$6,307$5,829$5,723
Other Curr. Assets$3,040$3,456$3,358$2,419
Total Curr. Assets$28,198$25,939$25,108$29,704
Property Plant & Equip (Net)$11,991$11,826$11,087$10,873
Goodwill$25,551$25,553$24,965$24,756
Intangibles$29,037$29,240$27,476$26,915
Long-Term Investments$2,153$2,161$2,095$1,128
Tax Assets$5,576$5,202$5,099$4,359
Other NC Assets$4,783$4,474$4,111$4,511
Total NC Assets$79,091$78,456$74,833$72,542
Other Assets$0$0$0$0
Total Assets$107,289$104,395$99,941$102,246
Liabilities
Payables$4,555$4,506$4,261$4,572
Short-Term Debt$7,784$8,573$8,043$8,324
Tax Payable$3,342$2,826$2,570$2,225
Deferred Revenue$0$0$0$127
Other Curr. Liab.$16,319$15,809$16,745$13,444
Total Curr. Liab.$32,000$31,714$31,619$28,692
LT Debt$24,238$24,064$23,227$22,934
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$2,171$2,321$2,548$2,419
Other NC Liab.$4,128$4,242$4,095$4,075
Total NC Liab.$30,537$30,627$29,870$29,428
Other Liabilities$0$0$0$0
Cap. Leases$1,904$1,853$1,803$1,803
Total Liabilities$62,537$62,341$61,489$58,120
Equity
Pref Stock$0$0$0$0
Common Stock$766$766$766$793
Retained Earnings$43,510$41,527$39,839$0
AOCI$98-$275-$2,217-$3,255
Other Equity-$44-$33-$19$46,508
Total Equity$44,330$41,985$38,369$44,046
Supplemental Information
Minority Interest$422$69$83$80
Total Liab. & Tot. Equity$107,289$104,395$99,941$102,246
Net Debt$22,466$25,981$24,204$19,799